Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SCT1000
BIOLOGICAL
2 trials
Sponsors
Sinocelltech Ltd.
Conditions
HPV Infection Vaccine Safety SCT1000
Interventional
Prevention
Randomized
Phase 1
A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
NCT04921111
Sinocelltech Ltd.
HPV Infection Vaccine Safety SCT1000
Start: 2021-07-02
End: 2022-10-31
Target: 240
Updated: 2021-09-17
Phase 2
A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years
NCT05060484
Sinocelltech Ltd.
Interventional, Prevention, Randomized
Start: 2021-10-19
End: 2022-07-31
Target: 1800
Updated: 2021-10-28